🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study was to evaluate the consistency between liver biopsy a...
Status
Completed
Location
Guven Hospital
Start Date
2023-01-02
Trial ID
NCT06573190
Treatments Being Tested
The aim of our study is: 1. The early detection of NAFLD in CKD patients w...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07
Trial ID
NCT04482153
Treatments Being Tested
Chronic viral hepatitis often leads to liver scarring - cirrhosis. If the v...
Status
Completed
Location
Bart's Health NHS
Start Date
2016-05
Trial ID
NCT02782247
Treatments Being Tested
The non-invasive assessment of liver fibrosis in chronic viral hepatitis B ...
Status
Completed
Location
University Hospital
Start Date
2012-01
Trial ID
NCT01537965
Aim of the research is to assess frequency of MAFLD among patients with acu...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-01
Trial ID
NCT06456970
Treatments Being Tested
Metabolic associated fatty liver disease (MAFLD) has currently reached a wo...
Status
Unknown
Location
Shanghai Tenth People's Hospital
Start Date
2017-01-01
Trial ID
NCT05525884
Treatments Being Tested
Interventional study with minimal risks and constraints, prospective, mono-...
Status
Completed
Location
Rennes University Hospital
Start Date
2017-06-27
Trial ID
NCT03174327
Treatments Being Tested
Non-alcoholic fatty liver disease (NAFLD), currently referred to as metabol...
Status
Completed
Location
Faculty of Pharmacy
Start Date
2023-04-04
Trial ID
NCT07338331
Treatments Being Tested
Hypothesis of this study is the existence of a relation between parameters ...
Status
Completed
Location
University Hospital of Tours
Start Date
2013-04
Trial ID
NCT02575625
Treatments Being Tested
The purpose of this study is to validate FibroScan and FibroSURE™ as equal ...
Status
Withdrawn
Location
University Hospitals Cleveland Medical Center
Start Date
2019-02-10
Trial ID
NCT03820934
Treatments Being Tested